iBio (IBIO) Assets Average (2011 - 2026)

iBio (IBIO) has 16 years of Assets Average data on file, last reported at $75.1 million in Q1 2026.

• On a quarterly basis, Assets Average rose 268.2% year-over-year to $75.1 million in Q1 2026; TTM through Mar 2026 was $75.1 million, a 268.2% increase from a year earlier, with the FY2025 full-year figure at $26.0 million, down 25.77% from the prior year.
• Assets Average for Q1 2026 stood at $75.1 million, up from $64.3 million in the prior quarter.
• Over the last five years, Assets Average for IBIO reached as high as $120.9 million in Q1 2022 and fell as low as $20.4 million in Q1 2025.
• Historically, Assets Average has averaged $53.6 million across 5 years, with a median of $42.8 million in 2023.
• Across the five-year window, Assets Average slumped 60.22% in 2023 and soared 268.2% in 2026, its largest moves.
• Year by year, Assets Average stood at $68.2 million in 2022, then sank by 47.42% to $35.8 million in 2023, then slumped by 35.55% to $23.1 million in 2024, then jumped by 178.16% to $64.3 million in 2025, then increased by 16.86% to $75.1 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $75.1 million in Q1 2026, $64.3 million in Q4 2025, and $43.7 million in Q3 2025.